Table 1 Patient, disease, and treatment characteristics of all the patients (n = 989).

From: Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer

Variable

N = 989

(%)

Age years

Median (years)

55

 

Range

26–87

 

BMI < 25

717

72.5

BMI ≥ 25

272

27.5

Histological type

Type I

820

82

Endometrioid G1

573

63

Endometrioid G2

234

26

Mucinous

3

0.3

Mixed (G1, G2, mucinous)

10

1.1

Type II

169

18

Endometrioid G3

52

5.7

Serous

22

2.4

Clear

12

1.3

Carcinosarcoma

34

3.7

Mixed (type II)

49

5.4

Peritoneal cytology

Positive

135

14

Negative

854

86

With myometrial invasion

556

56.2

Without myometrial invasion

433

43.8

LSVI positive

104

89.5

LSVI negatige

885

10.5

  1. BMI body mass index; Without myometrial invasion: endometrial cancer in which the malignant cells are histopathologically found only in the endometrium; myometrial invasion: endometrial cancer with myometrial invasion within 50%; LSVI lymphovascular space invasion.
Back to article page